Skymap Pharmaceuticals approved as strategic buyer of IMPCL for ₹121.01 crore
On 26 May 2026 the Centre approved Skymap Pharmaceuticals Pvt. Ltd.'s bid of about ₹121.01 crore for 100% equity and management control of Indian Medicines Pharmaceutical Corporation Limited (IMPCL), a CPSE under the Ministry of Ayush.
Summary
The Alternative Mechanism, a Group of Ministers empowered by the CCEA and comprising the Union Ministers for Road Transport and Highways, Finance and the MoS (IC) for Ayush, approved the highest bid of ₹121,00,94,400 by Skymap Pharmaceuticals Private Limited for 100% equity of IMPCL along with transfer of management control. IMPCL, incorporated on 12 July 1978, makes and supplies standardised Ayurvedic and Unani medicines. The CCEA gave in-principle approval for its strategic disinvestment in November 2017. Seven parties expressed interest after the PIM of 01.09.2023, and two financial bids were received by 20.01.2026; the winning bid was above the reserve price.
Key facts
- Company
- Indian Medicines Pharmaceutical Corporation Limited (IMPCL), CPSE under Ministry of Ayush
- Buyer
- Skymap Pharmaceuticals Pvt. Ltd.
- Price
- ₹121,00,94,400 (about ₹121.01 crore) for 100% equity
- Approved by
- Alternative Mechanism (GoM empowered by CCEA)
- IMPCL incorporated
- 12 July 1978; Ayurvedic and Unani medicines
- In-principle approval
- CCEA, November 2017
- Bids
- 7 EoIs; 2 financial bids by 20.01.2026
Practice MCQs 2 questions
Which company was approved in May 2026 as the strategic buyer for 100% equity of Indian Medicines Pharmaceutical Corporation Limited (IMPCL)?
Show answer
Correct answer: D — Skymap Pharmaceuticals Pvt. Ltd.
The Alternative Mechanism approved the highest bid of about ₹121.01 crore by Skymap Pharmaceuticals Private Limited.
Consider the following statements about IMPCL: 1. It was incorporated in 1978. 2. Its prime objective is manufacturing and supplying standardised Homoeopathic and Siddha medicines. Which of the statements given above is/are correct?
Show answer
Correct answer: A — 1 only
IMPCL was incorporated on 12 July 1978 with the prime objective of manufacturing and supplying standardised Ayurvedic and Unani medicines, not Homoeopathic and Siddha.